Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicines in China and internationally. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.
Frequently asked questions
What sector does Shandong Buchang Pharmaceuticals Co Ltd (603858) operate in?
Shandong Buchang Pharmaceuticals Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shandong Buchang Pharmaceuticals Co Ltd (603858) current stock price?
As of the latest data, Shandong Buchang Pharmaceuticals Co Ltd stock price is CN¥14.62, with a previous close of CN¥14.62.
What is Shandong Buchang Pharmaceuticals Co Ltd (603858) current market capitalization?
Shandong Buchang Pharmaceuticals Co Ltd market cap is approximately 15.42 billion.
What is Shandong Buchang Pharmaceuticals Co Ltd (603858) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.23.
What is Shandong Buchang Pharmaceuticals Co Ltd (603858) Price-to-Earnings (P/E) ratio?
Shandong Buchang Pharmaceuticals Co Ltd current P/E ratio is 63.57.
Does Shandong Buchang Pharmaceuticals Co Ltd (603858) pay dividends?
No. Shandong Buchang Pharmaceuticals Co Ltd does not pay a dividend.
What is Shandong Buchang Pharmaceuticals Co Ltd (603858) beta (volatility) score?
Shandong Buchang Pharmaceuticals Co Ltd has a beta of 0.296, indicating lower volatility than the overall market.